This is not the most recent version of the article. View current version (31 MAY 2013)

Overview of Reviews Protocol

Pharmacological interventions for smoking cessation: an overview of reviews

  1. Kate Cahill*,
  2. Tim Lancaster,
  3. Rafael Perera

Editorial Group: Cochrane Tobacco Addiction Group

Published Online: 7 SEP 2011

DOI: 10.1002/14651858.CD009329


How to Cite

Cahill K, Lancaster T, Perera R. Pharmacological interventions for smoking cessation: an overview of reviews (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD009329. DOI: 10.1002/14651858.CD009329.

Author Information

  1. University of Oxford, Department of Primary Care Health Sciences, Oxford, UK

*Kate Cahill, Department of Primary Care Health Sciences, University of Oxford, 23-38 Hythe Bridge Street, Oxford, OX1 2ET, UK. kate.cahill@phc.ox.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 7 SEP 2011

SEARCH

This is not the most recent version of the article. View current version (31 MAY 2013)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To conduct an overview of Cochrane reviews which assess the efficacy and safety of pharmacological interventions designed to assist smoking cessation attempts.

As part of this overview, we will address the following issues:

1. How do the three first-line treatments compare with each other for efficacy, defined in this overview as the achievement of long-term abstinence (six months or longer)? This question will be explored using direct and indirect comparisons where appropriate.

2. How do the risks of side effects and serious adverse events compare between the treatments, and are there instances where the harms may outweigh the benefits?

3. Are there limitations in the current evidence base which may compromise the precision or stability of any conclusions drawn by this overview? If so, what are the implications for future research?